Carvedilol Tablet, Film Coated
Product Images NDC 51655-397

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 51655-397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 01)

Chemical structure of Carvedilol, showing its molecular arrangement including aromatic rings, an ether linkage, and an alcohol functional group. This illustration depicts the compound's structural formula relevant to the active ingredient Carvedilol in the 25 mg film-coated tablet.*

FDA Label Image

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 02)

A line chart depicting cumulative percentage mortality over 21 months, comparing two groups labeled 'Placebo' and 'Carvedilol'. The 'Placebo' group shows higher mortality rates than the 'Carvedilol' group throughout the period. A p-value of 0.0014 is noted, indicating statistical significance.*

FDA Label Image

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 03)

A forest plot chart depicting hazard ratios with confidence intervals for various subgroups including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use. The horizontal axis represents hazard ratio values ranging roughly from 0.0 to 2.0, with subgroup data points and error bars shown along the axis.*

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 04)

A line graph showing % Mortality over time in months for two groups: Placebo and Carvedilol. The plot illustrates mortality rates increasing over 24 months, with the Carvedilol group showing lower mortality compared to Placebo. Statistical significance is indicated by P = 0.03 on the graph.*

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 05)

A forest plot chart displaying hazard ratios for various patient subgroups such as age, sex, prior conditions, Killip class, thrombolytic use, and comorbidities related to heart conditions including CHF, MI, angina, hypertension, diabetes, heart rate, and blood pressure. The plot shows hazard ratio estimates with confidence intervals for each subgroup comparison.*

FDA Label Image

Label (51655 397 52 Rev A 02 22 Nhc)

Carvedilol Tablets USP 25 mg, film-coated oral tablets. The label indicates a package of 30 tablets from Northwind Health Company, LLC, with instructions for storage, dosage reference, and handling precautions. The label includes the NDC 51655-397-52 and specifies prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.